Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion type Assertion NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_head.
- NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion description "[We analyzed the methylation pattern of 17 gene promoters in nine thyroid cancer cell lines and in 38 primary thyroid carcinomas (13 papillary thyroid carcinoma [PTC], 10 follicular thyroid carcinoma [FTC], 9 undifferentiated thyroid carcinoma [UTC], 6 medullary thyroid carcinoma [MTC]), 12 goiters, and 10 follicular adenomas (FA) by methylation- specific polymerase chain reaction (PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_provenance.
- NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion evidence source_evidence_literature NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_provenance.
- NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion SIO_000772 16889486 NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_provenance.
- NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion wasDerivedFrom befree-2016 NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_provenance.
- NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_assertion wasGeneratedBy ECO_0000203 NP562859.RAf9_eXU7UxvdGE4dNjVOXE-y_-blFtg_d-6Cub-UEC6M130_provenance.